1. IndiaInfoline
  2. News
  3. PR Newswire
PR Newswire News On IndiaInfoline.com
Result Express

    SPARC is awaiting USFDA approval on its late stage innovative drugs, Elepsia (Epilepsy drug) and Xelpros (Glaucoma drug). Both ...

    Accumulate Reco. Price: 383.95

  • Narayana Hrudaya

    Company operates an asset light model with lowest capital cost per operational bed than peers (Rs28lakh per bed in Q2FY18). We ...

    Accumulate Reco. Price: 244.60